Hiroshima, Japan

Miyuki Takashima

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wakunaga Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miyuki Takashima. Retrieved from https://idiyas.com/inventor/miyuki-takashima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Miyuki Takashima

Introduction

Miyuki Takashima is a notable inventor based in Hiroshima, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive agents. Her work is characterized by a focus on safety and mild effects, which are crucial for patient well-being.

Latest Patents

Miyuki Takashima holds a patent for an antihypertensive agent. This innovative agent comprises S-1-propenylcysteine or a salt thereof as an active ingredient. The patent emphasizes the safety and mild effect of the agent, making it a valuable addition to hypertension treatments. She has 1 patent to her name.

Career Highlights

Throughout her career, Miyuki has been associated with Wakunaga Pharmaceutical Co., Ltd., where she has contributed to various research and development projects. Her expertise in pharmacology has allowed her to make strides in creating effective and safe medications.

Collaborations

Miyuki has worked alongside talented colleagues, including Yukihiro Kodera and Mitsuyasu Ushijima. Their collaborative efforts have fostered an environment of innovation and creativity within their projects.

Conclusion

Miyuki Takashima's contributions to the field of antihypertensive agents highlight her dedication to improving patient care through innovative solutions. Her work continues to inspire future advancements in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…